70 participants
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-02-09
- Start Date:
- 2018-03-20
- Completion:
- 2019-12-18
Conditions
- Cancer
Interventions
- DRUG